Jellyfish mucin may have potential disease-modifying effects on osteoarthritis

BMC Biotechnology

Volumn 9, Issue , 2009, Pages

  Ohta, Naoshi ^a   Sato, Masato ^a   Ushida, Kiminori ^b   Kokubo, Mami ^a   Baba, Takayuki ^c   Taniguchi, Kayoko ^b   Urai, Makoto ^b   Kihira, Koji ^c   Mochida, Joji ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c Jellyfish Research Laboratories Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR CRUCIATE LIGAMENT; ARTICULAR CARTILAGE DEGENERATION; ARTICULAR CARTILAGES; AURELIA; CARTILAGE DEFECTS; FOUR-GROUP; HYALURONIC ACIDS; INTRA-ARTICULAR INJECTION; ION EXCHANGE CHROMATOGRAPHY; MODIFYING EFFECTS; OA MODEL; RABBIT KNEES;

BIOLOGICAL MATERIALS; CHROMATOGRAPHIC ANALYSIS; HOUSING; HYDROXYLATION; ION CHROMATOGRAPHY; ION EXCHANGE; LIGAMENTS; METAL VAPOR LAMPS; ORGANIC ACIDS; PURIFICATION; SURGERY; ULTRASONIC MEASUREMENT;

CARTILAGE;

HYALURONIC ACID; MUCIN; QNIUMUCIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE DEGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PURIFICATION; FEMALE; HISTOPATHOLOGY; ION EXCHANGE CHROMATOGRAPHY; JAPANESE; JELLYFISH; KNEE OSTEOARTHRITIS; NONHUMAN; RABBIT; ANIMAL; ARTICULAR CARTILAGE; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; INJURY; INTRAARTICULAR DRUG ADMINISTRATION; PATHOLOGY; SCYPHOZOA;

AURELIA AURITA; NEMOPILEMA NOMURAI; ORYCTOLAGUS CUNICULUS; SCYPHOZOA;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; FEMALE; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MUCINS; OSTEOARTHRITIS, KNEE; RABBITS; SCYPHOZOA;

EID: 74049130327     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-9-98     Document Type: Article

References (35)

1. Sato M, Mochida J. Osteoarthritis. Yakkyoku (Journal of Practical Pharmacy) 2007, 58:858-865.
2. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000, 43:1905-1915. 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P, 11014340.
3. Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK study group. Longitudinal investigation of nonsteroidal antiinflammatory drugs in knee osteoarthritis. J Rheumatol 1995, 22:1941-1946.
4. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989, 2:519-522. 10.1016/S0140-6736(89)90651-X, 2570233.
5. Dougados M, Gueguen A, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis 1996, 55:356-362. 10.1136/ard.55.6.356, 1010186, 8694574.
6. Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal anti-inflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum 2005, 52:3137-3142. 10.1002/art.21357, 16200593.
7. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. A randomized, doubleblind, placebo-controlled clinical trial. Arch Intern Med 2002, 162:292-298. 10.1001/archinte.162.3.292, 11822921.
8. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993, 1:97-103. 10.1016/S1063-4584(05)80024-X, 8886085.
9. Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 2006, 88:295-302. 10.2106/JBJS.E.00193, 16452740.
10. Y Kobayashi Y, A Okamoto A, K Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology 1994, 31:235-244.
11. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005, 115:622-631. 548698, 15719068.
12. Jay GD, Torres JR, Warman ML, Laderer MC, Breuer KS. The role of lubricin in the mechanical behavior of synovial fluid. Proc Natl Acad Sci USA 2007, 104:6194-6199. 10.1073/pnas.0608558104, 1851076, 17404241.
13. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992, 27:57-92. 10.3109/10409239209082559, 1727693.
14. Grundy MM, McKenzie JD, Richardson NV, Bavington CD, Mulloy B, Lever R, Page CP. Product from Starfish. US Patent No. 6991810 2000,
15. Kimura S, Gohda T, Sakurai Y. Characterization of nidamental mucin from Japanese common squid Todarodes pacificus. J Tokyo Univ Fish 2003, 89:7-13.
16. Masuda A, Baba T, Dohmae N, Yamamura M, Wada H, Ushida K. Mucin (qniumucin), a glycoprotein from jellyfish and determination of its main chain structure. J Nat Prod 2007, 70:1089-1092. 10.1021/np060341b, 17567171.
17. Konttinen YT, Saari H, Nordstrom DC. Effect of interleukin-1 on hyaluronate synthesis by synovial fibroblastic cells. Clin Rheumatol 1991, 10:151-154. 10.1007/BF02207654, 1914415.
18. Schiavinato A, Lini E, Guidolin D, Pezzoli G, Botti P, Martelli M, Cortivo R, De Galateo A, Abatangelo G. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Clin Orthop Relat Res 1989, 241:286-299.
19. Chang DP, Abu-Lail NI, Guilak F, Jay GD, Zauscher S. Conformational mechanics, adsorption and normal force interactions of lubricin and hyaluronic acid on model surfaces. Langmuir 2008, 24:1183-1193. 10.1021/la702366t, 18181652.
20. Davidson HJ, Kuonen VJ. The tear film and ocular mucins. Vet Ophthalmol 2004, 7:71-77. 10.1111/j.1463-5224.2004.00325.x, 14982585.
21. Taylor ME. Introduction to Glycobiology 2006, Oxford: Oxford University Press.
22. Glenister DA, Salamon KE, Smith K, Beighton D, Keevil CW. Enhanced growth of complex communities of dental plaque bacteria in mucin-limited continuous culture. Microb Ecol Health Dis 1988, 1:31-38.
23. Wu A, Csako G, Herp A. Structure, biosynthesis and function of salivary mucins. Mol Cell Biochem 1994, 137:39-55. 10.1007/BF00926038, 7845377.
24. Hashimoto Y, Hashimoto S, Pigman W. Purification and properties of porcine submaxillary mucin. Arch Biochem Biophys 1964, 104:282-291. 10.1016/S0003-9861(64)80015-1, 14163894.
25. Harding SE. An analysis of the heterogeneity of mucins. No evidence for a self-association. Biochem J 1984, 219:1061-1064. 1153583, 6743243.
26. Imura H, Mori T, Ohkura H, Ishii M, Ariyoshi H, Endo J, Kitao M, Takeda I, Kobayashi H, Inoue M, Hirota M, Yanakido M, Hakomori S, Kannagi R. Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen; (1) Evaluation of assay conditions and normal values. Jpn J Cancer Chemother 1989, 16:3213-3219.
27. Adikwu MU, Alozie BU. Application of snail mucin dispersed in detarium gum gel in wound healing. Sci Res Essay 2007, 2:195-198.
28. Yoshioka M, Coutts RD, Amiel D, Hacker SA. Characterization of a model of osteoarthritis in the rabbit knee. Osteoarthritis Cartilage 1996, 4:87-98. 10.1016/S1063-4584(05)80318-8, 8806111.
29. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998, 41:1266-1274. 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y, 9663485.
30. Amiel D, Toyoguchi T, Kobayashi K, Bowden K, Amiel ME, Healey RM. Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis Cartilage 2003, 11:636-643. 10.1016/S1063-4584(03)00119-5, 12954234.
31. Jo H, Ahn HJ, Kim EM, Kim HJ, Seong SC, Lee I, Lee MC. Effects of dehydroepiandrosterone on articular cartilage during the development of osteoarthritis. Arthritis Rheum 2004, 50:2531-2538. 10.1002/art.20368, 15334467.
32. Batiste DL, Kirkley A, Laverty S, Thain LM, Spouge AR, Gati JS, Foster PJ, Holdsworth DW. High-resolution MRI and micro-CT in an ex vivo rabbit anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 2004, 12:614-626. 10.1016/j.joca.2004.03.002, 15262241.
33. Boulocher C, Duclos ME, Arnault F, Roualdes O, Fau D, Hartmann DJ, Roger T, Vignon E, Viguier E. Knee joint ultrasonography of the ACLT rabbit experimental model of osteoarthritis: relevance and effectiveness in detecting meniscal lesions. Osteoarthritis Cartilage 2008, 16:470-479. 10.1016/j.joca.2007.07.012, 17889569.
34. Jean YH, Wen ZH, Chang YC, Hsieh SP, Lin JD, Tang CC, Chen WF, Chou AK, Wong CS. Increase in excitatory amino acid concentration and transporters expression in osteoarthritis knee of anterior cruicate ligament transected rabbits. Osteoarthritis Cartilage 2008, 16:1442-1449. 10.1016/j.joca.2008.04.008, 18524638.
35. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.